Credits: Canva
Until law, GLP-1 drugs were used to treat diabetes, obesity and even the recent evidences suggest that it could as well be used to treat chronic kidney problems. There is yet another research, published in JAMA Psychiatry on February 25, titled Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial that explores if GLP-1 receptor agonist semaglutide reduce alcohol consumption and cravings in adults with alcohol use disorder.
The research was conducted over a period of 9 weeks, where in the randomized clinical trial, the participants who were administered semaglutide, it led to reductions in some but not all measures of weekly consumptions. It also reduced weekly alcohol and craving related to placebo, and also led to a greater relative reduction in cigarettes per day.
The research also found that weekly injections of semaglutide, which is the active ingredient in weight loss drugs like Wegovy also helped reduce cravings in people with alcohol use disorder.
The lead author Christian Hendershot said that these findings will help in developing new approaches to treat alcoholism. "Two drugs currently approved to reduce alcohol consumption aren't widely used. The popularity of Ozempic and other GLP-1 receptor agonists increases the chances of broad adoption of these treatments for alcohol use disorder," said Hendershot in news release by the University of Southern California's Institute for Addiction Research, where he is the director.
The study is government-funded research and was funded by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.
The study was small, and took in account for only 48 adults over two months, thus experts say that it is not yet clear how safe these drugs are for people who do not need to lose weight. Though the results do add up with the evidence form animal studies on drugs like Ozempic and Wegovy on how it helps manage cravings, not just for food, but also for tobacco and alcohol. Scientists are also studying these drugs on smokers, people with opioid addiction and cocaine users.
Co-author Dr Klara Klein of the University of North Carolina at Chapel Hill who treats people with obesity and diabetes said, "This is such promising data. And we need more of it. We frequently will hear that once people start these medications that their desire to drink is very reduced, if not completely abolished."
The GLP-1 receptor agonists work by mimicking hormones GLP-1 in the gut and brain that regulates appetite and feelings of fullness. This response is what helps one lose weight, and what helps one curb their craving for alcohol. These drugs that mimic the functioning of your brain, which is responsible to tell your body when to stop consuming, are the same hormones that tell your body about other kinds of consumptions, including alcohol. Therefore by consuming the weight loss drugs one can treat alcohol use disorder.
However, the researchers have pointed out on the limited data on the research and have suggested to continue using the three approved drugs by the National Institute on Alcohol Abuse and Alcoholism and Substance Abuse and Mental Health Services Administration, namely, Disulfiram, Naltrexone, and Acamprosate to treat alcohol use disorder until large studies confirm these findings.
Credit: Mark Kelly/X
Actress Olivia Munn has joined US Senator Mark Kelly to push for legislation that would make breast cancer risk assessments a routine part of healthcare for American women, helping them understand their individual risk and access appropriate screening.
Together, they have introduced the Know Your Risk Act, which aims to expand access to validated breast cancer risk assessment tools and integrate them into routine healthcare.
Munn, who was diagnosed with breast cancer in 2023, said a risk assessment prompted her doctor to recommend further testing despite her having a normal mammogram and negative genetic testing. The additional tests detected an aggressive cancer early.
"Had it not been for that assessment, my breast cancer may not have been identified when it was," Munn said while announcing the legislation alongside Kelly.
Also read: World Breast Cancer Day 2026: Life After Breast Cancer, The Fear No One Sees
Announcing the legislation outside the US Capitol, Kelly said existing breast cancer risk assessment tools are not being used widely enough, leaving many women unaware of their individual risk.
"These tools already exist, but too often doctors aren't using them and women don't know that they're available," Kelly said.
The Democratic senator from Arizona said the Act would make breast cancer risk assessments a routine part of healthcare, helping women and their doctors understand individual risk and determine appropriate screening.
"Women shouldn't have to ask for these assessments. They should be part of regular care like getting a blood pressure reading taken," Kelly said.
He added that the legislation had bipartisan support, with lawmakers recognizing the importance of expanding access to early detection.
Munn's experience highlights why individual risk assessments matter, particularly when standard screening and genetic testing may not identify a woman's breast cancer risk.
Despite having a normal mammogram and negative genetic testing, her risk assessment prompted further investigations that led to her diagnosis.
She said the experience motivated her to work with Kelly to ensure other women have access to similar assessments.
According to the World Health Organization (WHO), breast cancer caused an estimated 694,000 deaths worldwide in 2024. It was the most commonly diagnosed cancer among women in 164 of 186 countries.
In the US, breast cancer is the second leading cause of cancer death among women, according to the Centers for Disease Control and Prevention (CDC).
Early detection can significantly improve breast cancer outcomes. According to the National Cancer Institute, the five-year relative survival rate for women with localized breast cancer is more than 99%.
During the announcement, a representative of breast cancer organization Susan G. Komen highlighted the difference between detecting the disease before and after it spreads, noting that survival rates can fall to around 30% when breast cancer is diagnosed at a distant stage.
The representative also pointed to the rising number of diagnoses among women under 50, many of whom may not consider themselves at risk.
The Know Your Risk Act seeks to address this gap by expanding access to validated risk assessment tools, helping women and their doctors better understand individual risk and make informed decisions about screening.
Credit: AI
New rules to govern organ donation in the United States went into effect from Wednesday, November 18, 2026. According to the latest safeguards, before organ recovery can begin, a minimum five-minute observation period is mandatory after a patient's circulation stops.
The rules come amid concerns about patients showing signs of neurological activity during the organ recovery procedure and also whether it had been adequately confirmed that the patient died.
The rules apply to donation after circulatory death (DCD), a process in which organs may be recovered after a patient's heart and circulation have stopped. They are not applicable to every form of organ donation.
The new requirements were developed under the Health Resources and Services Administration (HRSA) and the Organ Procurement and Transplantation Network (OPTN). They include additional safeguards, including stronger and clearer neurological checks, a formal process to pause donation when safety concerns arise, and more transparent communication with families.
The changes come after HRSA probed into organ procurement systems. In July 2025, the US Department of Health and Human Services said it had examined 351 cases in which organ donation had been authorised but ultimately did not proceed.
The review found concerning details in 103 cases, including 73 patients who showed neurological signs that were considered incompatible with organ donation. It also found that at least 28 patients may not have been deceased when organ recovery was initiated.
On a wider front, the investigation sparked questions about the inadequacy of neurological assessments, coordination between hospitals and organ procurement organisations, and the documentation of death. HRSA subsequently directed the OPTN to strengthen safeguards across the donation process.
Also read: Not Everyone With Obesity Is Unhealthy: New Study Challenges BMI
Under the new policy, an observation period of at least five minutes must pass after circulation has ceased before organ recovery can begin.
The aim is to confirm that the heart does not restart spontaneously, a rare phenomenon called autoresuscitation. It is also sometimes called the Lazarus phenomenon.
In DCD, a patient's life-saving treatment is stopped after a decision made by the patient or their legally authorised representative in consultation with the doctors.
If the patient dies after their heart and circulation stop, organ donation may proceed after death has been determined with complete certainty and the mandatory observation period completed.
Also read: Life At Any Cost: Why We Fight To Prolong Life But Question The Idea To Ease Death?
Apart from the five-minute observation period, the new also include:
Credit: AP Photos
After 26 years, the US has lost its measles elimination status, marking a major setback for public health efforts. The resurgence has intensified criticism of Health and Human Services Secretary Robert F. Kennedy Jr. over his vaccine policies and rhetoric.
The Pan American Health Organization (PAHO) confirmed that the US had lost the status it maintained since 2000.
The country has recorded more than 5,700 measles cases and 11 deaths. Pennsylvania, the hardest-hit state, has reported its eighth measles-associated death of 2026.
A CDC-led report identified 112 measles infections among pregnant women in the US between January 2025 and September 2026, along with 13 cases of congenital measles in newborns.
The actual number may be higher. A separate CIDRAP News investigation based on state health department data identified at least 167 pregnant women infected in 2025 and 2026.
“Even though measles is an old disease, measles in pregnancy is an emerging area that we need to learn about,” said Michelle Barton, a professor at the Schulich School of Medicine & Dentistry at Western University.
Decades of MMR vaccination meant many doctors had never encountered measles during their medical careers. However, declining vaccination rates have allowed the disease to spread in under-vaccinated communities.
Criticism of Kennedy has crossed party lines. Republican Senator Bill Cassidy of Louisiana on Sunday criticised what he called a "series of failures" under Kennedy's leadership at the Department of Health and Human Services.
"This has been a failure. If I were president, I would choose someone else because there needs to be accountability for higher health care costs, more measles deaths, losing elimination status, and no progress on processed foods," Cassidy said on CBS News.
Democratic senators Angela Alsobrooks and Patty Murray have also called for Kennedy's removal.
Alsobrooks (Maryland) condemned the loss of measles elimination status and called Kennedy's tenure a disgrace. She had called for his resignation or dismissal in May 2025. Her resolution of disapproval against Kennedy now has 28 Senate co-sponsors.
Senator Richard Blumenthal (Connecticut) has demanded answers over the alleged suppression of a CDC warning about measles risks during pregnancy, while criticising the administration's vaccine policies.
Murray (Washington) has blamed Trump and Kennedy's leadership for the loss of elimination status and repeatedly called for Kennedy's removal.
Read More: What Happens After Measles Infection? The Hidden Risks That Can Last For Years
Democratic governors have also blamed Kennedy for the setback. New York Governor Kathy Hochul said the loss of measles elimination status contradicted Kennedy's promise to make America healthy again.
"RFK Jr. promised to 'Make America Healthy Again.' Now America has lost its measles-free status for the first time in 26 years," Hochul said.
"A disgraceful display of incompetence from the nation's highest public health office," she added.
Pennsylvania Governor Josh Shapiro blamed vaccine misinformation and skepticism for the setback. "There is a clear line from the misinformation, vaccine skepticism, and incompetence of RFK Jr. to this devastating news and very real consequences," Shapiro said.
Kentucky Governor Andy Beshear explicitly demanded Kennedy's removal. "This dangerous setback was 100% avoidable and is the result of one person: RFK Jr.," Beshear said. "Remove him now."
An HHS spokesperson rejected the governors' criticism in a statement to Fox News Digital, calling their attacks "baseless" and arguing that declining vaccination rates predated the Trump administration.
The spokesperson said the administration remained focused on expanding vaccine access, closing immunisation gaps and assisting state and local officials with outbreak investigations.
Kennedy has vowed to stop measles outbreaks and restore the country's elimination status while continuing to recommend vaccination.
"We will stop measles outbreaks, protect American families, and work to regain U.S. measles elimination status," Kennedy said in a statement.
"I continue to recommend MMR vaccination as the most effective way to prevent measles," he added.
© $2026 Times Horizon Private Limited